Routine Angiographic Follow-Up versus Clinical Follow-Up after Percutaneous Coronary Intervention in Acute Myocardial Infarction
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Differences in the utility of routine angiographic follow-up (RAF) and clinical follow-up (CF) after percutaneous coronaryintervention (PCI) in acute myocardial infarction (AMI) are not well understood. The present study aimed to compare the 3-year clinical outcomes of RAF and CF in AMI patients who underwent PCI with drug-eluting stents (DES). Materials and Methods: A total of 774 consecutive AMI patients who underwent PCI with DES were enrolled. RAF was performedat 6 to 9 months after index PCI (n=425). The remaining patients were medically managed and clinically followed (n=349); symptom-driven events were captured. To adjust for any potential confounders, a propensity score matched analysis was performedusing a logistic regression model, and two propensity-matched groups (248 pairs, n=496, C-statistic=0.739) were generated. Cumulative clinical outcomes up to 3 years were compared between RAF and CF groups. Results: During the 3-year follow-up period, the cumulative incidences of revascularization [target lesion revascularization: hazardratio (HR), 2.40; 95% confidence interval (CI), 1.18–4.85; p=0.015, target vessel revascularization (TVR): HR, 3.33; 95% CI, 1.69–6.58; p=0.001, non-TVR: HR, 5.64; 95% CI, 1.90–16.6; p=0.002] and major adverse cardiac events (MACE; HR, 3.32; 95% CI, 1.92–5.73; p<0.001) were significantly higher in the RAF group than the CF group. However, the 3-year incidences of death and myocardial infarction were not different between the two groups. Conclusion: RAF following index PCI with DES in AMI patients was associated with increased incidences of revascularization and MACE. Therefore, CF seems warranted for asymptomatic patients after PCI for AMI.
Abstract
Purpose: Differences in the utility of routine angiographic follow-up (RAF) and clinical follow-up (CF) after percutaneous coronaryintervention (PCI) in acute myocardial infarction (AMI) are not well understood. The present study aimed to compare the 3-year clinical outcomes of RAF and CF in AMI patients who underwent PCI with drug-eluting stents (DES). Materials and Methods: A total of 774 consecutive AMI patients who underwent PCI with DES were enrolled. RAF was performedat 6 to 9 months after index PCI (n=425). The remaining patients were medically managed and clinically followed (n=349); symptom-driven events were captured. To adjust for any potential confounders, a propensity score matched analysis was performedusing a logistic regression model, and two propensity-matched groups (248 pairs, n=496, C-statistic=0.739) were generated. Cumulative clinical outcomes up to 3 years were compared between RAF and CF groups. Results: During the 3-year follow-up period, the cumulative incidences of revascularization [target lesion revascularization: hazardratio (HR), 2.40; 95% confidence interval (CI), 1.18–4.85; p=0.015, target vessel revascularization (TVR): HR, 3.33; 95% CI, 1.69–6.58; p=0.001, non-TVR: HR, 5.64; 95% CI, 1.90–16.6; p=0.002] and major adverse cardiac events (MACE; HR, 3.32; 95% CI, 1.92–5.73; p<0.001) were significantly higher in the RAF group than the CF group. However, the 3-year incidences of death and myocardial infarction were not different between the two groups. Conclusion: RAF following index PCI with DES in AMI patients was associated with increased incidences of revascularization and MACE. Therefore, CF seems warranted for asymptomatic patients after PCI for AMI.
참고문헌 (19)
- 최윤정, "Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea", Yonsei Medical Journal, 56(4), pp.895~903 (2015), 연세대학교의과대학[DOI]
- Ayman Tantawy, "Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching", Yonsei Medical Journal, 58(2), pp.290~295 (2017), 연세대학교의과대학[DOI]
- Garg S, "Coronary stents: current status", J Am Coll Cardiol, 56(10 Suppl), pp.S1~S42 (2010)
- Kirtane AJ, "Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies", Circulation, 119, pp.3198~3206 (2009)
- Cutlip DE, "Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials", J Am Coll Cardiol, 40, pp.2082~2089 (2002)
- King SB 3rd, "2007 focused update of the ACC", AHA, American Heart Association Task Force on Practice guidelines, pp.J Am Coll Cardiol, 2008[DOI]
- Silber S, "Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology", Eur Heart J, 26, pp.804~847 (2005)
- Pijls NH, "Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study", J Am Coll Cardiol, 49, pp.2105~2111 (2007)
- Mindrescu C, "Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for STsegment elevation myocardial infarction", J Interv Cardiol, 26, pp.319~324 (2013)
- Stone GW, "A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease", N Engl J Med, 350, pp.221~231 (2004)
- Moses JW, "Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery", N Engl J Med, 349, pp.1315~1323 (2003)
- Pinto DS, "O’Shaughnessy C, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial", J Am Coll Cardiol, 48, pp.32~36 (2006)
- Lasala JM, "Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry", Catheter Cardiovasc Interv, 72, pp.433~445 (2008)
- Uchida T, "The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of “oculostenotic”reintervention in patients with intermediate lesions", JACC Cardiovasc Interv, 3, pp.403~411 (2010)
- Stone GW, "Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial", J Am Coll Cardiol, 56, pp.1597~1604 (2010)
- De Luca G, "Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials", Int J Cardiol, 133, pp.213~222 (2009)
- Asakura M, "Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up", Circulation, 97, pp.2003~2006 (1998)
- Hochman JS, "Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators", N Engl J Med, 341, pp.226~232 (1999)
- Lansky AJ, "Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years", Am J Cardiol, 110, pp.21~29 (2012)